![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Liver Cirrhosis |
|
Free Subscription
3 BMC Gastroenterol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Changing etiological spectrum of cirrhosis in China: a systematic review and
meta-analysis.
BMC Gastroenterol. 2026 Jun 12. doi: 10.1186/s12876-026-05009.
PubMed
Abstract available
Moderate alcohol consumption and clinical outcomes in MASLD: a systematic review
and meta-analysis of longitudinal cohorts.
BMC Gastroenterol. 2026;26:368.
PubMed
Abstract available
A novel serum metabolite classifier for identifying Metabolic
Dysfunction-Associated Steatotic Liver Disease (MASLD) integrating metabolomics
and machine learning.
BMC Gastroenterol. 2026;26:361.
PubMed
Abstract available
Clin Res Hepatol Gastroenterol
Dipstick urinary chloride as a surrogate marker of urinary sodium in cirrhosis: a
prospective multicenter pilot study.
Clin Res Hepatol Gastroenterol. 2026 Jun 16:102871.
PubMed
Abstract available
Incidence of Cirrhosis in Fibrotic Metabolic Dysfunction-Associated
Steatohepatitis: A Meta-Analysis of Placebo Arms from Randomized Clinical Trials.
Dig Dis Sci. 2026 Jun 18. doi: 10.1007/s10620-026-10057.
PubMed
Abstract available
Head-to-head comparison between vibration-controlled transient elastography and
histology in predicting liver-related events due to metabolic
dysfunction-associated steatotic liver disease.
Hepatology. 2026;84:175-190.
PubMed
Abstract available
HBV induces liver fibrosis through the generation of reactive oxygen species in a
pyruvate-dependent manner.
Hepatology. 2026;84:216-232.
PubMed
Abstract available
Predictors of fibrosis, clinical events, and mortality in MASLD: Data from the
Global-MASLD study.
Hepatology. 2026;84:204-215.
PubMed
Abstract available
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD
study.
Hepatology. 2026;84:161-174.
PubMed
Abstract available
Hepatocyte-derived extracellular vesicles promote endothelial dedifferentiation
in chronic liver disease through the miR-153-3p - pyroptosis axis.
Hepatology. 2025 Oct 10. doi: 10.1097/HEP.0000000000001567.
PubMed
Abstract available
Reprogramming macrophages to treat liver diseases.
Hepatology. 2026;84:251-272.
PubMed
Abstract available
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B
- follow-up from the RETRACT-B cohort.
J Hepatol. 2026 Mar 30:S0168-8278(26)00185-6. doi: 10.1016/j.jhep.2026.
PubMed
Abstract available
Longitudinal changes in cardiometabolic risk factors are associated with changes
in liver stiffness in adults with MASLD.
J Hepatol. 2026;85:37-47.
PubMed
Abstract available
Thank you for your interest in scientific medicine.